« Return to News | CROs/Service Providers | Miscellaneous

PPD Opens CRO’s Largest Safety Center in Bulgaria

Friday, May 7, 2010 08:25 AM

Wilmington, N.C.-based PPD opened a pharmacovigilance and medical communications center in Sofia, Bulgaria, in response to growing client demand for drug safety, medical information and medical writing services in the region. This new facility is PPD’s largest safety center and its third European hub for medical communications contact center services. The company also has centers in Athlone, Ireland, and Stockholm, Sweden.

"Expanding our safety and medical communications operations in Europe strengthens our ability to bring high quality global health care expertise to provide these services in an efficient, cost-effective and regulatory compliant manner," said PPD’s chief medical officer Christine Dingivan, M.D., in a statement. "There is strong demand for both pre- and post-approval safety services, and we have an experienced management team on the ground in Bulgaria to oversee our operations and to create customized programs that meet client needs."

PPD already has hired more than 20 employees for the Sofia center—most of them physicians, pharmacists, nurses and medical specialists—and plans to hire 200 more in the coming year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.